Heart design: free ADP scales with absolute mitochondrial and myofibrillar volumes from mouse to human  by Dobson, Geoffrey P & Himmelreich, Uwe
Heart design: free ADP scales with absolute mitochondrial and
myo¢brillar volumes from mouse to human
Geo¡rey P. Dobson *, Uwe Himmelreich 1
Department of Physiology and Pharmacology, James Cook University, Townsville, Qld 4811, Australia
Received 10 January 2001; received in revised form 15 November 2001; accepted 21 November 2001
Abstract
Our aim was to estimate a number of bioenergetic parameters in the beating mouse, rat and guinea pig heart in situ and
compare the values to those in hearts of mammals over a 2000-fold range in body mass. For the mouse, rat and guinea pig
heart, we report a phosphorylation ratio of 1005 þ 50 (n = 16), 460 þ 32 (n = 10) and 330 þ 22 (n = 5) mM31 and a free
cytosolic [ADP] concentration of 13, 18 and 22 WM, respectively. When each parameter was plotted against body mass, they
scaled closely to the quarter power (30.28, r = 0.99 and 30.23, r = 0.97). A similar regression slope was found when the
inverse of free [ADP] was plotted against absolute mitochondrial (slope =30.26, r = 0.99) and myofibrillar volumes
(slope =30.24, r = 0.99). The similar slopes indicate that the ratio of absolute mitochondria and myofibrillar volumes in the
healthy mammalian heart is a constant, and independent of body size. In conclusion, our study supports the hypothesis that
the mammalian heart has a number of highly conserved thermodynamic and kinetic parameters that obey quarter-power
laws linking the phosphorylation ratio, ATP turnover rates, free [ADP] and absolute mitochondrial volumes to body size.
The results are discussed in terms of possible mechanisms and potential deviations from these laws in some disease
states. ß 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
The energy cost of living is more expensive if you
are small. One gram of mouse heart, for example,
consumes 7^10 times more oxygen (and therefore
ATP) than 1 g of human tissue [2]. Smaller mammals
per unit body mass consume more oxygen, eat more
food, produce more heat and live shorter lives com-
pared to larger ones [1^5]. When plotted on logarith-
mic coordinates the mass-speci¢c oxygen consump-
tion scales inversely with body size with a regression
slope of a quarter power or 0.25 [2,6].
VO2=Pmet  0:676 M30:25b 1
where VO2/Pmet is the mass-speci¢c oxygen consump-
tion in liters O2 per kilogram body mass per hour [2].
Higher mass-speci¢c oxygen consumption rates have
been associated with increased maximal enzyme ac-
tivities of key glycolytic and Krebs cycle enzymes
0005-2728 / 01 / $ ^ see front matter ß 2002 Elsevier Science B.V. All rights reserved.
PII: S 0 0 0 5 - 2 7 2 8 ( 0 1 ) 0 0 2 4 7 - X
Abbreviations: PCr, phosphocreatine; Cr, creatine; CK, crea-
tine kinase; Pi, inorganic phosphate; ATP, adenosine 5P-triphos-
phate; ADP, adenosine 5P-diphosphate; free [Mg2], unbound
magnesium; 31P-NMR, phosphorus nuclear magnetic resonance;
Vmit and Vmyofib, total volume of mitochondria and myo¢brils,
respectively; VO2 , volume of oxygen consumed by the body
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[5,7,8], increased cytochrome oxidase activities and
contents [9,10], as well as absolute mitochondrial vol-
umes [11^18]. Other physiological variables such as
heart rate, respiratory rate, tissue blood £ow and
food intake have also been shown to scale which
led West and colleagues to propose a general model
for the origin of the scaling relationships based on
the transport of materials through linear networks
that branch to supply all parts of the organism [19].
In heart, the scaling of two metabolic parameters
that have received little attention are free cytosolic
[ADP] and the cytosolic phosphorylation ratio
([ATP]/[ADP][Pi]) and their relationships to absolute
mitochondrial and myo¢brillar volumes [20]. Free
[ADP] is important because of its possible role in
the regulation of oxygen consumption in heart and
skeletal muscle [21] and [ATP]/[ADP][Pi] for provid-
ing the cellular driving potential between ATP and
its products ADP and Pi. The [ATP]/[ADP][Pi] is
linked to the transformed Gibbs energy through
vGPATP =vGP‡ATP+RT ln([ADP][Pi]/[ATP]) [22,23].
Thus, the ¢rst aim of this study was to test our scal-
ing hypothesis in hearts of smaller mammals using a
purpose built 31P-NMR surface coil and a DEPTH
pulse sequence was chosen to reduce contamination
from chamber blood. The second aim was to estab-
lish the relationship between free cytosolic [ADP]
(and the [ATP]/[ADP][Pi] ratio) and absolute mito-
chondrial and myo¢brillar volumes over a 2000-fold
di¡erence in heart mass and body size.
2. Materials and methods
2.1. In situ heart preparation
Healthy, mature Quacker-bush mice (32 þ 2 g),
Sprague^Dawley rats (300 þ 16 g) and guinea pigs
(850 þ 45 g) were anesthetized with Nembutal (V60
mg/kg body wt.) (Boehringer Ingelheim). A tracheot-
omy was performed and animals were arti¢cially ven-
tilated with a Harvard small animal ventilator. The
displacement volumes and rates were: mouse (1.5 ml,
165 min31), rat (3 ml, 60^70 min31) and guinea pig
(4^4.5 ml, 45 min31). The heart was exposed by a
thoracotomy and the animal placed in a tempera-
ture-controlled animal cradle (38‡C). A purpose built
31P-NMR surface coil with a £exible arm was posi-
tioned against the left ventricular myocardium
[20,24]. The cradle was introduced into the horizon-
tal bore magnet about 20 min after the commence-
ment of surgery and remained in the magnet for the
duration of the experiment (usually 1^2 h). A sepa-
rate group of animals (12 mice, three rats and three
guinea pigs) were anesthetized and instrumented for
the biochemical determination of the total creatine
(Cr) concentration (see below). Heart tissue was
freeze-clamped in tongs cooled in liquid N2. Frozen
wafers were stored at 380‡C until analyzed.
2.2. NMR experiments
31P-NMR spectra were recorded at 121.452 MHz
with a 11 cm horizontal bore, 7.05 Tesla magnet
connected to a Varian INOVA console. A three-
turn coil with an inner diameter of 3.5 mm was built
from enameled copper wire (W3124, Versa Elec-
tronics, Australia) of 0.5 mm thickness. The coil
was tuned and matched with ceramic capacitors of
variable capacity to resonate at 121.45 MHz. The Q-
factor of the coil was 102 in air (unloaded) and 47
when loaded. The signal was maximized by shim-
ming the 31P-NMR surface coil o¡-resonance on
the myocardial 1H-NMR signal. A DEPTH pulse
sequence (180‡^90‡^180‡^180‡) [25,26] was used to
obtain 512 signal-averaged FIDs. A relaxation delay
of 2 s was applied. Calibration factors compensating
for partial saturation were determined by comparing
spectra using the 2 s relaxation delay with fully re-
laxed spectra with a relaxation delay of 5UT1 (15 s
for the metabolites in the hearts in situ and 60 s for
the phenylphosphonate in the phantom, respectively)
[24]. A coil sensitive depth pro¢le was determined
with a phantom consisting of four layers of a known
thickness (between 0.8 and 1.1 mm) and containing
10 mM of di¡erent phosphorylated compounds.
From this procedure it was possible to determine
the excitation band of the coil. Metabolite concen-
trations in the 31P-NMR spectra were quanti¢ed by
comparison of the respective signal areas from the
tissue to an external standard containing 10 mM
phenylphosphonite that was placed directly on top
of the surface coil in exactly the same geometrical
arrangement. We believe that this method provides
similar molar sensitivities in the standard and tissue
as shown by Hitchins et al. [27].
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2.3. Calculation of phosphorus metabolites,
[ATP]/[ADP][Pi] ratio and free [ADP]
The concentration of ATP, phosphocreatine (PCr)
and Pi were determined from the integrals of the in
situ 31P-NMR spectrum using the DEPTH pulse se-
quence relative to phosphorus signal in the external
standard. To calculate ATP concentrations from the
NMR spectrum ATP was assumed to equal 93% of
the L-NTP (nucleoside triphosphate) intensity [28].
The intracellular space of 73% of the total tissue
water was used for calculation of cell concentrations
where TTW = 0.79 ml g wet wt.31 [29,32].
Free cytosolic [ADP] and [ATP]/[ADP][Pi] were
calculated by substituting the metabolic data (in
moles/l cell water) into the creatine kinase equil-
ibrium after adjusting the creatine kinase (CK) con-
stant to the pH and free [Mg2] of the heart [23].
Total creatine was determined separately on freeze-
clamped hearts by measuring PCr and Cr enzymati-
cally using £uorometric procedures [30]. Total crea-
tine (PCr+Cr) was measured enzymatically on freeze-
clamped tissue and found to be 17 þ 0.71 Wmoles
ml31 intracellular water (n = 8, S.E.M.), and intracel-
lular Cr concentration calculated from subtracting
the NMR derived PCr from the total Cr concentra-
tion. Cytosolic free [Mg2] was estimated from the
chemical shift di¡erence of the K- and L-resonances
of ATP [31] and pH was determined either from the
chemical shift of the Pi signal relative to the PCr
signal or alternatively from the chemical shift di¡er-
ence of the L- and Q-resonances of ATP [32].
2.4. Estimation of cardiac output of di¡erent
mammals and absolute mitochondrial and
myo¢brillar volumes
The cardiac outputs of the mouse, human and
elephant were calculated from the relation Qh = 187
M0:81b where Qh is the cardiac output (ml min
31) and
Mb is body mass in kg [2]. The cardiac output for the
30 g mouse was 10 ml min31 (heart rate 600 beats
min31), for the 70 kg human 5 l min31 (heart rate 70
beats min31), and for the 3800 kg elephant 148 l
min31 (heart rate 30 beats min31). The heart weight
of the mouse was 0.15 g, the human heart was 400 g
and the elephant heart 19 kg. The life span of a
mouse is 3 years, of a human 70 years and of an
elephant 50 years. Similar calculations have shown
the same for the number of heart beats over a life
time (about 1500 million heartbeats) but notable ex-
ceptions exist [1]. Absolute mitochondrial volumes in
hearts of di¡erent species were obtained from volume
densities reported by Kim et al. [18], Schaper et al.
[13] and Hoppler et al. [12]. The absolute volume of
heart mitochondria (Vmit) was obtained by multiply-
ing the volume densities with heart mass and divid-
ing by the density of muscle tissue (1.06 g cm33)
[12].
2.5. Statistics
Unless stated otherwise, all values shown are
means þ S.E.M. with the number of samples in pa-
rentheses. Linear regression analysis was used to de-
termine the relationship between the bioenergetic
parameters and body or heart mass, or absolute
mitochondrial and myo¢brillar volumes. The error
bars represent the standard error of the mean. The
level of statistical signi¢cance was P6 0.05.
3. Results
Representative 31P-NMR spectra of the guinea
pig, rat and mouse heart are shown in Fig. 1a, b
and c respectively. The DEPTH pulse sequence
(180‡^90‡^180‡^180‡) did not exceed 1 mm (approx-
imate thickness of the left ventricle of the mouse) and
was veri¢ed using a multi-layer phantom (data not
shown). A comparison with data acquired with a 30‡
pulse sequence revealed a marked suppression of
contaminating phosphate at the inorganic phosphate
resonance that we assume was 2,3-diphosphoglycer-
ate in the vascular and ventricular blood.
The 31P-NMR determined metabolites and bioen-
ergetic parameters in hearts of three mammalian spe-
cies are reported in Table 1. The [PCr]/[ATP] ratios
in situ were 2.70 þ 0.08 (S.E.M., n = 16), 2.40 þ 0.03
(n = 10) and 2.30 þ 0.04 (n = 5) in mouse, rat and
guinea pig heart, respectively, for a cytosolic free
[ADP] of 12.9, 17.5 and 21.8 WM (Table 1). The
phosphorylation ([ATP]/[ADP][Pi]) ratios in the
mouse, rat and guinea pig heart in vivo were 1005,
460 and 330 mM31 for a vGPATP of 370, 367.5 and
366.5 kJ mol31 (Table 1). These ratios for the
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mouse, rat and guinea pig are also in good agree-
ment with values predicted from the relationship
[ATP]/[ADP][Pi] (mM) = 386.4 M30:30b [20]. Fig. 2a
shows the relationship between the myocardial
[ATP]/[ADP][Pi] and heart mass which scales with a
regression slope 30.28 (r = 0.99). The equation de-
scribing the relationship between the heart cytosolic
phosphorylation ratio and mass-speci¢c tissue oxy-
gen consumption is [ATP]/[ADP][Pi] = (VO2 /Pmet)
1:18
(r = 0.99) with [ATP]/[ADP][Pi] in mM31 and VO2 /
Pmet in liters O2 h31 kg31 (graph not shown). Fig.
2b shows a similar relationship and slope between
the inverse of free cytosolic [ADP] and heart mass
(regression slope =30.23, r = 0.98). The similar
slopes between Fig. 2a and b demonstrate that the
major factor maintaining the higher phosphorylation
ratio in smaller mammalian hearts is the mainte-
nance of lower micromolar concentrations of free
cytosolic [ADP].
Fig. 2c shows the relationship between the inverse
of free myocardial cytosolic [ADP] and absolute mi-
tochondrial and myo¢brillar volumes (cm3). The re-
gression slope describing free [ADP] and mitochon-
drial volume was 30.26 (r = 0.99) and free [ADP]
and myo¢brillar volume was 30.24 (r = 0.98), and
close to a quarter power.
4. Discussion
Our study demonstrates a number of ¢ndings:
¢rst, the heart cytosolic phosphorylation ratio
(ATP/ADP Pi) and the inverse of free [ADP] both
scale with body mass with a slope close to a quarter
power (Fig. 2a,b), and second, the inverse of free
[ADP] also scales with absolute volumes of mito-
chondrial (Vmit) or myo¢brillar volumes (Vmyofib)
with similar quarter-power slopes (Fig. 2c). It is pro-
posed that these mass-speci¢c quarter-power allomet-
ric relations have important implications in under-
standing cardiac function in health and disease (see
below).
Fig. 1. 31P-NMR spectra of the resting (non-paced) in situ
heart ventricle of guinea pig (a), rat (b) and mouse (c). Spectra
were acquired with a DEPTH pulse sequence (180‡^90‡^180‡^
180‡^acq.). A total of 512 signal-averaged FIDs were acquired
(total NMR time: 17 min). Absolute concentrations of phos-
phorylated metabolites in the myocardium were calculated by
comparison with an external standard (10 mM phenylphos-
phonite, PP) that was placed on top of the coil in a similar
geometric arrangement compared to the heart (see Section 2).
Table 1
31P-NMR determined metabolites and bioenergetic parameters in mouse, rat and guinea pig hearts in situ
Species n PCr ATP Free Mg2 pHi Free ADP Pi ATP/ADP Pi vGPATP
Mouse (32 g) 22 13.8 þ 0.3 4.9 þ 0.1 0.41 þ 0.02 7.32 þ 0.02 12.9 þ 0.3 6 0.4 1005 þ 43 369.9
Rat (300 g) 10 12.2 þ 0.31 5.4 þ 0.09 0.45 þ 0.08 7.27 þ 0.03 17.5 þ 0.6 0.79 þ 0.03 460 þ 32 367.5
Guinea pig
(850 g)
5 11.4 þ 0.45 5.6 þ 0.13 0.48 þ 0.02 7.25 þ 0.02 21.8 þ 0.9 0.98 þ 0.04 330 þ 22 366.5
Values are expressed in mM with the exception of free ADP (WM) and vGPATP (kJ mol31). Creatine [Cr] was calculated by subtracting
the NMR derived PCr from the total Cr [TCr] determined by biochemical assay where the [TCr] for mouse, rat and guinea pig heart
was 18.8 þ 0.43 (n = 12), 23.7 þ 0.3 (n = 3) and 25.9 þ 0.5 (n = 3). Conversion of total tissue content (Wmol/g wet wt.) to intracellular con-
centrations (mM) was performed using intracellular space of 73% and total tissue water of 0.79 g H2O g31 wet tissue determined in
heart (see text). Values are mean þ S.E.
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4.1. Scaling of the myocardial phosphorylation ratio
and free [ADP]
When the heart ATP/ADP Pi ratio or inverse of
free [ADP] is plotted as a function of body mass
(Table 1, Fig. 2a,b), the regression lines have slopes
of 30.28 (r = 0.99) and 30.23 (r = 0.97), respectively,
and support the bioenergetic scaling hypothesis of
Dobson and Headrick [20]. The higher phosphoryla-
tion ratio, higher vGPATP, and higher mass-speci¢c
metabolic rate in the mouse heart is consistent with
the scaling of a number of key glycolytic and mito-
chondrial enzymes in smaller mammals [5,7,8], in-
cluding a higher capacity for Ca2 re-uptake by the
sarcoplasmic reticulum required with higher myosin
ATPase activities [33]. However, it is not known
whether the higher myocardial phosphorylation ra-
tios (and lower free [ADP]) in the mouse heart are
maintained at higher mitochondrial proton motive
forces and/or higher NADH/NAD ratios than in
hearts of larger species.
4.2. Scaling of absolute mitochondrial and
myo¢brillar volumes
The second major ¢nding of the present study was
that the inverse of free [ADP] from mouse to human
also scaled close to the quarter power with absolute
volumes of mitochondrial (Vmit) and myo¢brillar vol-
umes (Vmyofib). To our knowledge, this is the ¢rst
time free [ADP] and absolute mitochondrial and
myo¢brillar volumes have been shown to scale with
body mass (and heart mass) in mammals. Previous
work on mitochondrial scaling in heart has concen-
trated on the relation to body mass, and maximal
whole body oxygen consumption. In 1984, Hoppeler
and colleagues found that the absolute volume of
mitochondria in heart from shrew to cow also scaled
against body mass with a slope of 0.93 [12].
Our observation that free [ADP] is lower as the
absolute mitochondrial (and myo¢brillar) volume in-
creases with decreasing heart (and body) size is sig-
ni¢cant given that free [ADP] has been reported to
be a potential regulator of oxygen consumption
[21,34]. Not only do increased absolute mitochon-
drial volumes lead to increased ATP turnover rates
in the hearts of smaller mammals, but the lower
steady-state concentration of [ADP] may provide
Fig. 2. Correlation between cardiac bioenergetic parameters,
mass and mitochondrial and myo¢brillar volumes from mouse
to human. (a) Cytosolic phosphorylation ratio as function of
mammalian heart mass (Mb, kg). The equation to the line is
[ATP]/[ADP][Pi] (mM) = 559.86 M30:28b (r = 0.99). (b) Cytosolic
free [ADP] (WM) as a function of heart mass (Mb, kg) is
[1/ADP] = 0.0583 M30:23b (r = 0.97). (c) Cytosolic free [ADP]
(WM) as a function of absolute mitochondrial and myo¢brillar
volumes (cm3). For mitochondria (E) Vmit the equation to the
line is [1/ADP] = 0.0416 (Vmit)30:26 (r = 0.99). For myo¢brillar
volumes (a), Vmyofib, the equation to the line is [1/ADP]
= 0.0492 (Vmyofib)30:24 (r = 0.98). Absolute mitochondrial vol-
umes in hearts of di¡erent species were obtained from Kim et
al. [18], Schaper et al. [13] and Hoppler et al. [12].
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greater gain in controlling the rate of oxygen con-
sumption. The low concentration of free [ADP] is
similar to the apparent Km value of oxidative phos-
phorylation in isolated mitochondria (20^30 WM)
[35]. However, it should be emphasized that correla-
tions between free [ADP] and cardiac oxygen con-
sumption do not imply causality, and further studies
are required to settle this issue.
Another important ¢nding of the present study
was the observation that the ratio of absolute myo¢-
brillar to mitochondrial volume in heart is a con-
stant, and independent of body size in mammals.
From the similar slope of regression lines in Fig.
2c, the ratio was calculated to be around 2^1 ^ or
the absolute myo¢brillar volume is 2 times the abso-
lute mitochondrial volume in the mammalian heart.
The relation expressed mathematically is Vmit = 0.52
(Vmyofib)0:93 (r = 0.99) where Vmit is the absolute mi-
tochondrial and Vmyofib the absolute myo¢brillar vol-
ume (graph not shown). Maintaining this precise ra-
tio in heart appears to be essential in coupling ATP
utilization to ATP synthesis.
Disruption of this ratio of absolute myo¢brillar to
mitochondrial volume is likely to be associated with
morphological, cellular, metabolic and bioenergetic
dysfunction such as in cardiac hypertrophy, a signi¢-
cant risk factor for congestive heart failure. Ultra-
structural studies of Breisch et al. in cats have shown
that there is indeed a mismatch in the myo¢brillar to
mitochondrial ratio at 4 and 7 days of pressure over-
load hypertrophy, which then returns to normal after
30 days [36]. However, in later stages (120^148 days)
an increase in the absolute mitochondrial volume rel-
ative to the myo¢brillar volume occurs along with a
continual decrease in capillary density and reduced
cardiac function [36]. More recently, the importance
of maintaining a ¢xed ratio of 2 between absolute
volume of myo¢brils and mitochondria was shown
in the study of Knaapen and colleagues during the
development of embryonic rat myocardium (11^17
days) [37].
4.3. Signi¢cance of ¢ndings and perspective
The question of central importance in this study is
what is the signi¢cance of a mass-speci¢c quarter-
power allometry that is so pervasive in mammals,
and other multicellular organisms. This question
has entertained physiologists for over 100 years since
the original observations of Rubner [2]. The most
recent attempt to explain the mass-speci¢c quarter-
power law is by West and colleagues who argue that
multicellular organisms have evolved hierarchical
branching networks that terminate in size-invariant
units such as capillaries and mitochondria [38]. Nat-
ural selection has tended to maximize both metabolic
capacity and internal e⁄ciency; the former by max-
imizing the scaling of exchange surface areas, and the
latter by minimizing the scaling of transport distan-
ces and times [38]. Thus, according to this model, the
scaling of metabolic rate and bioenergetic parameters
in heart, and their precise relations to absolute mito-
chondria and myo¢brillar volumes, appear to be the
result of evolutionary selection to maximize the ca-
pacities to deliver and exchange oxygen and oxidiz-
able fuels and remove waste products over optimal
transport distances and times. These mass-speci¢c
quarter-power laws in heart, and the design con-
straints they underpin, appear to be highly conserved
phenomena. To give an example of how the scaling
of structural, metabolic and bioenergetic para-
meters lead to highly conserved features in the mam-
malian heart design, the tiny mouse heart weighing
0.15 g and beating at 600 beats min31 will pump
similar blood volumes on a mass basis over a 3 year
life span as the 0.4 kg human heart beating at
70 beats min31 over a 70 year life span, or the
19 kg elephant heart beating at 30 beats min31
over a 50 year life span. The volume of blood
pumped per kg for the mammalian heart over its
respective life span is around 300 000 000 l kg heart31
lifetime31.
4.4. Conclusion
We conclude that the abilities of the mouse heart
to pump faster than the human heart over a 2000-
fold di¡erence in body mass is a direct consequence
of negative quarter-power allometric laws built into
its structural, metabolic and bioenergetic design. Our
scaling data indicate that there is a natural selection
of ‘¢tness’ per gram heart where mass-speci¢c (neg-
ative) quarter-power scaling is a highly conserved
consequence of supplying a whole animal with linear
networks to meet a (positive) three-quarter-power
scaled whole organism.
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